Oscar Health reported approximately 37% year-over-year revenue growth in the most recent quarter, driven by a 42% increase in individual market premiums and a 31% gain in group plan contributions. Management reiterated guidance for roughly 30% topline growth over the next 12 months, underpinned by new enrollment initiatives in three additional states and enhanced digital member engagement tools that have boosted retention rates by 8 percentage points.

In response to margin pressures from elevated medical cost trends, Oscar Health plans a weighted average rate increase of about 28% for 2026 across its core markets. Executives believe this measured adjustment will preserve competitive position while directly addressing underwriting losses, which narrowed from a 6.2% loss ratio to a 3.4% loss ratio over the last two quarters. The company expects combined medical cost ratio improvements of 150 basis points once the rate increases take full effect.

Despite significant revenue acceleration and a narrowing underwriting deficit, Oscar Health’s share price has remained largely unchanged since the prior coverage date, implying a misalignment between market valuation and operational improvement. Institutional ownership has climbed to 42% from 35% a year ago, yet implied forward valuation multiples appear to discount long-term earnings power, creating a potential asymmetric upside if management executes on its margin roadmap.

Oscar Health continues to invest in technology and analytics, allocating 12% of revenues to IT and data science initiatives this year compared with 9% in 2023. These investments aim to optimize care management and lower per-member per-month costs by as much as 10% over the next two years. With a 2–3 year investment horizon in view, the company highlights its ability to drive sustainable compound growth by leveraging digital insurance platforms and scaling into new geographies.